Bli medlem
Bli medlem

Du är här


Endurance Specialty Holdings Ltd: Endurance Specialty Holdings Comments on Aspen Insurance Holdings' Poison Pill Adoption

PEMBROKE, Bermuda, April 17, 2014 - Endurance Specialty Holdings Ltd.
("Endurance") (NYSE: ENH) today commented on Aspen Insurance Holdings
Limited's ("Aspen's") (NYSE: AHL) adoption of a poison pill "shareholder
rights plan" in response to Endurance's April 14 proposal to acquire all of
the common shares of Aspen for $3.2 billion, or $47.50 per Aspen share, with
a combination of cash and Endurance common shares.

Michael J. McGuire, Chief Financial Officer of Endurance, said: "At a time
when the Aspen board should be seriously considering an opportunity to
deliver significant value to its shareholders, it is instead focused on
blocking them from receiving that value and on taking actions to entrench
themselves. This is not a surprise given the lack of alignment and clear
disdain Aspen's Board has shown for its shareholders in summarily rejecting
our proposal without any discussion whatsoever.

"A poison pill is a well documented defensive step typically taken by an
entrenched board of directors. It's interesting Aspen's Board adopted a
poison pill that divides their shareholders into different categories - good
and bad, passive and active - a division that is currently the subject of
litigation in an unrelated situation.

"As if it weren't clear before, Aspen shareholders now have further evidence
of their Board's deliberate actions to prevent them from receiving attractive
value for a strategically sound acquisition. We remain fully committed to
delivering our highly attractive premium offer to Aspen shareholders," Mr.
McGuire concluded.

For additional information about Endurance's proposal to acquire Aspen,
including a slide presentation for investors, please

About Endurance Specialty Holdings

Endurance Specialty Holdings Ltd. is a global specialty provider of property
and casualty insurance and reinsurance. Through its operating subsidiaries,
Endurance writes agriculture, professional lines, property, and casualty and
other specialty lines of insurance and catastrophe, property, casualty,
professional liability and other specialty lines of reinsurance. We maintain
excellent financial strength as evidenced by the ratings of A (Excellent)
from A.M. Best (XV size category) and A (Strong) from Standard and Poor's on
our principal operating subsidiaries. Endurance's headquarters are located
at Wellesley House, 90 Pitts Bay Road, Pembroke HM 08, Bermuda and its
mailing address is Endurance Specialty Holdings Ltd., Suite No. 784, No. 48
Par-la-Ville Road, Hamilton HM 11, Bermuda. For more information about
Endurance, please

Cautionary Note Regarding Forward-Looking Statements

Some of the statements in this press release may include forward-looking
statements which reflect our current views with respect to future events and
financial performance. Such statements may include forward-looking statements
both with respect to us in general and the insurance and reinsurance sectors
specifically, both as to underwriting and investment matters. These
statements may also include assumptions about our proposed acquisition of
Aspen (including its benefits, results, effects and timing). Statements
which include the words "should," "would," "expect," "intend," "plan,"
"believe," "project," "anticipate," "seek," "will," and similar statements of
a future or forward-looking nature identify forward-looking statements in
this press release for purposes of the U.S. federal securities laws or
otherwise. We intend these forward-looking statements to be covered by the
safe harbor provisions for forward-looking statements in the Private
Securities Litigation Reform Act of 1995.

All forward-looking statements address matters that involve risks and
uncertainties. Accordingly, there are or may be important factors that could
cause actual results to differ materially from those indicated in the
forward-looking statements. These factors include, but are not limited to,
the effects of competitors' pricing policies, greater frequency or severity
of claims and loss activity, changes in market conditions in the agriculture
insurance industry, termination of or changes in the terms of the U.S.
multiple peril crop insurance program, a decreased demand for property and
casualty insurance or reinsurance, changes in the availability, cost or
quality of reinsurance or retrocessional coverage, our inability to renew
business previously underwritten or acquired, our inability to maintain our
applicable financial strength ratings, our inability to effectively integrate
acquired operations, uncertainties in our reserving process, changes to our
tax status, changes in insurance regulations, reduced acceptance of our
existing or new products and services, a loss of business from and credit
risk related to our broker counterparties, assessments for high risk or
otherwise uninsured individuals, possible terrorism or the outbreak of war, a
loss of key personnel, political conditions, changes in accounting policies,
our investment performance, the valuation of our invested assets, a breach of
our investment guidelines, the unavailability of capital in the future,
developments in the world's financial and capital markets and our access to
such markets, government intervention in the insurance and reinsurance
industry, illiquidity in the credit markets, changes in general economic
conditions and other factors described in our Annual Report on Form 10-K for
the year ended December 31, 2013. Additional risks and uncertainties related
to the proposed transaction include, among others, uncertainty as to whether
Endurance will be able to enter into or consummate the transaction on the
terms set forth in the proposal, the risk that our or Aspen's shareholders do
not approve the transaction, potential adverse reactions or changes to
business relationships resulting from the announcement or completion of the
transaction, uncertainties as to the timing of the transaction, uncertainty
as to the actual premium of the Endurance share component of the proposal
that will be realized by Aspen shareholders in connection with the
transaction, competitive responses to the transaction, the risk that
regulatory or other approvals required for the transaction are not obtained
or are obtained subject to conditions that are not anticipated, the risk that
the conditions to the closing of the transaction are not satisfied, costs and
difficulties related to the integration of Aspen's businesses and operations
with Endurance's businesses and operations, the inability to obtain, or
delays in obtaining, cost savings and synergies from the transaction,
unexpected costs, charges or expenses resulting from the transaction,
litigation relating to the transaction, the inability to retain key
personnel, and any changes in general economic and/or industry specific

Forward-looking statements speak only as of the date on which they are made,
and we undertake no obligation publicly to update or revise any
forward-looking statement, whether as a result of new information, future
developments or otherwise.

Regulation G Disclaimer

In this press release, Endurance has included certain non-GAAP measures.
Endurance management believes that these non-GAAP measures, which may be
defined differently by other companies, better explain the proposed
transaction in a manner that allows for a more complete understanding.
However, these measures should not be viewed as a substitute for those
determined in accordance with GAAP. For a complete description of non-GAAP
measures and reconciliations, please review the Investor Financial Supplement
on Endurance's website at

Return on Equity (ROE) is comprised using the average common equity calculated
as the arithmetic average of the beginning and ending common equity balances
for stated periods.

Third Party-Sourced Information

Certain information included in this press release has been sourced from third
parties. Endurance does not make any representations regarding the accuracy,
completeness or timeliness of such third party information. Permission to
cite such information has neither been sought nor obtained.

All information in this press release regarding Aspen, including its
businesses, operations and financial results, was obtained from public
sources. While Endurance has no knowledge that any such information is
inaccurate or incomplete, Endurance has not had the opportunity to verify any
of that information.

Additional Information

This press release does not constitute an offer to sell or the solicitation of
an offer to buy any securities or a solicitation of any vote or approval.

All references in this press release to "$" refer to United States dollars.

The contents of any website referenced in this press release are not
incorporated by reference herein.


Endurance Specialty Holdings Ltd.
Investor Relations
Phone: +1 441 278 0988

Media Relations
Ruth Pachman and Thomas Davies
Kekst and Company
Phone: 212 521 4891/4873
Email: and

# # #


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Endurance Specialty Holdings Ltd via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.